Name | Label | Folder | |
---|---|---|---|
nsrrid
NSRR Subject ID
|
NSRR Subject ID
This subject identifier was created by the National Sleep Research Resource (NSRR) team to more easily match with file downloads. Use 'pptid' to link with Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC) and cohort-specific data. |
Administrative | |
pptidr
Randomized ID: Incorporates parent study random ID
|
Randomized ID: Incorporates parent study random ID
This participant ID matches what is present in Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC). |
Administrative | |
visitnumber
Sleep Heart Health Study (SHHS) Visit Number
|
Sleep Heart Health Study (SHHS) Visit Number | Administrative | |
bmi_s1
Body mass index (BMI) (Sleep Heart Health Study Visit One (SHHS1))
|
Body mass index (BMI) (Sleep Heart Health Study Visit One (SHHS1))
Body Mass Index (BMI) at Sleep Heart Health Study Visit One (SHHS1) |
Anthropometry | |
bmi_s2
Body mass index (BMI) (Sleep Heart Health Study Visit Two (SHHS2))
|
Body mass index (BMI) (Sleep Heart Health Study Visit Two (SHHS2))
Body Mass Index (BMI) at Sleep Heart Health Study Visit Two (SHHS2) |
Anthropometry | |
height
Height (Sleep Heart Health Study Visit One (SHHS1))
|
Height (Sleep Heart Health Study Visit One (SHHS1))
The SHHS Coordinating Center bottom and top coded this variable using a lower limit of 145 centimeters and an upper limit of 188 centimeters. |
Anthropometry | |
hip
Hip Circumference (Sleep Heart Health Study Visit One (SHHS1))
|
Hip Circumference (Sleep Heart Health Study Visit One (SHHS1))
Hip measurement in centimeters |
Anthropometry | |
pm202
Weight (Sleep Heart Health Study Visit Two (SHHS2))
|
Weight (Sleep Heart Health Study Visit Two (SHHS2))
The SHHS Coordinating Center bottom and top coded this variable using a lower limit of 47 kilograms and an upper limit of 126 kilograms. |
Anthropometry | |
pm207
Height (Sleep Heart Health Study Visit Two (SHHS2))
|
Height (Sleep Heart Health Study Visit Two (SHHS2))
The SHHS Coordinating Center bottom and top coded this variable using a lower limit of 145 centimeters and an upper limit of 188 centimeters. |
Anthropometry | |
waist
Waist Circumference (Sleep Heart Health Study Visit One (SHHS1))
|
Waist Circumference (Sleep Heart Health Study Visit One (SHHS1))
Waist measurement in centimeters |
Anthropometry | |
weight
Weight (Sleep Heart Health Study Visit One (SHHS1))
|
Weight (Sleep Heart Health Study Visit One (SHHS1))
The SHHS Coordinating Center bottom and top coded this variable using a lower limit of 47 kilograms and an upper limit of 126 kilograms. |
Anthropometry | |
fev1
Forced Expiratory Volume (FEV 1) (Sleep Heart Health Study Visit One (SHHS1))
|
Forced Expiratory Volume (FEV 1) (Sleep Heart Health Study Visit One (SHHS1))
in One Second |
Clinical Data/Diagnostic Studies/Lung Function | |
fvc
Forced Vital Capacity (FVC) (Sleep Heart Health Study Visit One (SHHS1))
|
Forced Vital Capacity (FVC) (Sleep Heart Health Study Visit One (SHHS1)) | Clinical Data/Diagnostic Studies/Lung Function | |
afibincident
Incident Atrial Fibrillation (AF) after SHHS Visit 1
|
Incident Atrial Fibrillation (AF) after SHHS Visit 1
Variable created as part of the analysis for Tung et al. 2017 (PubMed ID: 28668820). Incident AF was considered present if AF was identified on a 12-lead ECG obtained at the second SHHS exam or was adjudicated by the parent cohorts at any time between the baseline PSG and the final follow-up date for AF ascertainment of June 30, 2006. |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
afibprevalent
Prevalent Atrial Fibrillation (AF) at SHHS Visit 1
|
Prevalent Atrial Fibrillation (AF) at SHHS Visit 1
Variable created as part of the analysis for Tung et al. 2017 (PubMed ID: 28668820). Prevalent AF was defined by any of the following: a positive response to the question 'Has a doctor ever told you that you have or had atrial fibrillation'; AF identified on resting 12-lead ECG at the baseline SHHS exam; or if the parent study identified AF documented in the medical record before the SHHS baseline exam. |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
angina
Number of Angina Episodes Since Baseline
|
Number of Angina Episodes Since Baseline
Angina episodes since baseline Polysomnogram (PSG) (as recorded in parent studies datasets) |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
any_chd
Any Coronary Heart Disease (CHD) Since Baseline?
|
Any Coronary Heart Disease (CHD) Since Baseline?
Any Coronary Heart Disease (CHD) since baseline Polysomnogram (PSG) (as recorded in parent studies datasets) |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
any_cvd
Any Cardiovascular Disease (CVD) Since Baseline?
|
Any Cardiovascular Disease (CVD) Since Baseline?
Any Cardiovascular Disease (CVD) since baseline Polysomnogram (PSG) (as recorded in parent studies datasets) |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
cabg
Number of coronary artery bypass graft surgeries (CABGs) Since Baseline
|
Number of coronary artery bypass graft surgeries (CABGs) Since Baseline
coronary artery bypass graft surgery (CABG) since baseline Polysomnogram (PSG) (as recorded in parent studies datasets) |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
chd_death
Fatal Coronary Heart Disease (CHD) Since Baseline?
|
Fatal Coronary Heart Disease (CHD) Since Baseline?
Coronary Heart Disease (CHD) death (as recorded in parent studies datasets) |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
chf
Number of Congestive Heart Failures (CHFs) Since to Baseline
|
Number of Congestive Heart Failures (CHFs) Since to Baseline
Congestive Heart Failure (CHF) since baseline Polysomnogram (PSG) (as recorded in parent studies datasets) |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
cvd_death
Fatal Cardiovascular Disease (CVD) Since Baseline?
|
Fatal Cardiovascular Disease (CVD) Since Baseline?
Cardiovascular Disease (CVD) death (as recorded in parent studies datasets) |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
mi
Number of myocardial infarctions (MIs) Since Baseline
|
Number of myocardial infarctions (MIs) Since Baseline
Myocardial infarction (MI) since baseline Polysomnogram (PSG) (as recorded in parent studies datasets) |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
mi_death
Death from myocardial infarct (MI) since Baseline?
|
Death from myocardial infarct (MI) since Baseline? | Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
mi_fatal
Fatal Heart Attack Since Baseline?
|
Fatal Heart Attack Since Baseline?
Fatal myocardial infarction (MI) since baseline Polysomnogram (PSG) (as recorded in parent studies datasets) |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
mip
Number of Procedures Related to Heart Attack Since Baseline
|
Number of Procedures Related to Heart Attack Since Baseline
Myocardial infarction (MI) procedure since baseline Polysomnogram (PSG) (as recorded in parent studies datasets) |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
prev_ang
Number of Angina Episodes Prior to Baseline
|
Number of Angina Episodes Prior to Baseline
Angina episodes prior to baseline Polysomnography (PSG) (as recorded in parent studies datasets) |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
prev_chf
Number of Congestive Heart Failure (CHF) episodes Prior to Baseline
|
Number of Congestive Heart Failure (CHF) episodes Prior to Baseline
Congestive Heart Failure (CHF) episodes prior to baseline Polysomnography (PSG) (as recorded in parent studies datasets) |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
prev_mi
Number of myocardial infarctions (MIs) Prior to Baseline
|
Number of myocardial infarctions (MIs) Prior to Baseline
Myocardial infarction (MI) prior to baseline Polysomnography (PSG) (as recorded in parent studies datasets) |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
prev_mip
Number of Procedures Related to Heart Attack Prior to Baseline
|
Number of Procedures Related to Heart Attack Prior to Baseline
Myocardial infarction (MI)/procedure prior to baseline Polysomnography (PSG) (as recorded in parent studies datasets) |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
prev_revpro
Number of Revascularization Procedures Prior to Baseline
|
Number of Revascularization Procedures Prior to Baseline
Revascularization procedure prior to baseline Polysomnography (PSG) (as recorded in parent studies datasets) |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
prev_stk
Number of Strokes Prior to Baseline
|
Number of Strokes Prior to Baseline
Stroke prior to baseline Polysomnography (PSG) (as recorded in parent studies datasets) |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
ptca
Number of Percutaneous transluminal coronary angioplasties (PTCAs) Since Baseline
|
Number of Percutaneous transluminal coronary angioplasties (PTCAs) Since Baseline
Percutaneous transluminal coronary angioplasty (PTCA) since baseline Polysomnogram (PSG) (as recorded in parent studies datasets) |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
revasc_proc
Number of Revascularization Procedures Since Baseline
|
Number of Revascularization Procedures Since Baseline
Revascularization procedure since baseline Polysomnogram (PSG) (as recorded in parent studies datasets) |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
stk_fatal
Fatal Stroke Since Baseline?
|
Fatal Stroke Since Baseline?
Fatal stroke since baseline Polysomnogram (PSG) (as recorded in parent studies datasets) |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
stroke
Number of Strokes Since Baseline
|
Number of Strokes Since Baseline
Stroke since baseline Polysomnogram (PSG) (as recorded in parent studies datasets) |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
vital
Vital status at last contact
|
Vital status at last contact
Deaths from any cause were identified and confirmed for the cohort using multiple concurrent approaches including follow-up interviews, written annual questionnaires or telephone contacts with study participants or next-of-kin, surveillance of local hospital records and community obituaries, and linkage with the Social Security Administration Death Master File. (For more information, see Punjabi et al. 2009 (PubMed ID: 19688045)) |
Clinical Data/Incident Outcomes/Cardiovascular Diseases | |
chol
Cholesterol
|
Cholesterol | Clinical Data/Laboratory Tests | |
hdl
High-density lipoprotein (HDL) cholesterol
|
High-density lipoprotein (HDL) cholesterol | Clinical Data/Laboratory Tests | |
trig
Triglycerides
|
Triglycerides | Clinical Data/Laboratory Tests | |
diasbp
Average Diastolic blood pressure (BP) (Sleep Heart Health Study Visit One (SHHS1))
|
Average Diastolic blood pressure (BP) (Sleep Heart Health Study Visit One (SHHS1))
Seated Diastolic Blood Pressure (BP) |
Clinical Data/Vital Signs/Seated Blood Pressure/SHHS1 | |
systbp
Average Systolic blood pressure (BP) (Sleep Heart Health Study Visit One (SHHS1))
|
Average Systolic blood pressure (BP) (Sleep Heart Health Study Visit One (SHHS1))
Seated Systolic Blood Pressure (BP) (Average of two measurements) |
Clinical Data/Vital Signs/Seated Blood Pressure/SHHS1 | |
avg23bpd_s2
Average Diastolic blood pressure (BP) (Sleep Heart Health Study Visit Two (SHHS2))
|
Average Diastolic blood pressure (BP) (Sleep Heart Health Study Visit Two (SHHS2))
Average of 2nd and 3rd Diastolic Blood Pressure (BP) measures |
Clinical Data/Vital Signs/Seated Blood Pressure/SHHS2 | |
avg23bps_s2
Average Systolic blood pressure (BP) (Sleep Heart Health Study Visit Two (SHHS2))
|
Average Systolic blood pressure (BP) (Sleep Heart Health Study Visit Two (SHHS2))
Average of 2nd and 3rd Systolic Blood Pressure (BP) measures |
Clinical Data/Vital Signs/Seated Blood Pressure/SHHS2 | |
ethnicity
Ethnicity (Hispanic or Latino) of the participant
|
Ethnicity (Hispanic or Latino) of the participant
Note: This variable was derived from |
Demographics | |
gender
Gender of the participant
|
Gender of the participant
Gender as reported by Parent Cohort |
Demographics | |
race
Race of the participant
|
Race of the participant
Race is presented as three (3) categories based on suggested Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC) de-identification procedures. |
Demographics | |
educat
Education level of the participant
|
Education level of the participant | Demographics/Education | |
age_category_s1
Age at Sleep Heart Health Study Visit One (SHHS1)
|
Age at Sleep Heart Health Study Visit One (SHHS1)
Age at time of study in years, based on start date of Sleep Heart Health Study Visit One (SHHS1) Polysomnography (PSG) recording. |
Demographics/SHHS1 | |
age_s1
Age at Sleep Heart Health Study Visit One (SHHS1)
|
Age at Sleep Heart Health Study Visit One (SHHS1)
Age at time of study in years, based on start date of Sleep Heart Health Study Visit One (SHHS1) Polysomnography (PSG) recording. Values equal to 90 indicate an age of 90 or greater. |
Demographics/SHHS1 | |
mstat
Marital status of the participant
|
Marital status of the participant | Demographics/SHHS1 | |
age_category_s2
Age at Sleep Heart Health Study Visit Two (SHHS2)
|
Age at Sleep Heart Health Study Visit Two (SHHS2)
Age at time of study in years, based on start date of Sleep Heart Health Study Visit One (SHHS1) Polysomnography (PSG) recording. |
Demographics/SHHS2 | |
age_s2
Age at Sleep Heart Health Study Visit Two (SHHS2)
|
Age at Sleep Heart Health Study Visit Two (SHHS2)
Age in years at the time of the Sleep Heart Health Study Visit Two (SHHS2) visit. Values equal to 90 indicate an age of 90 or greater. |
Demographics/SHHS2 | |
nsrr_bmi
Body mass index (BMI)
|
Body mass index (BMI)
Harmonized by the NSRR team to align with TOPMed and BioDataCatalyst standards. Source: bmi_s1 at Visit 1, and bmi_s2 at Visit 2 |
Harmonized/Anthropometry | |
nsrr_bp_diastolic
Diastolic blood pressure
|
Diastolic blood pressure
Average resting diastolic blood pressure of two measurements collected from the upper arm in a single clinic visit. When more than two measurements were collected, the average was calculated using the second and third measurements. In cases where either of the measurements was missing, the average was calculated discarding the missing value. |
Harmonized/Clinical Data | |
nsrr_bp_systolic
Systolic blood pressure
|
Systolic blood pressure
Average resting systolic blood pressure of two measurements collected from the upper arm in a single clinic visit. When more than two measurements were collected, the average was calculated using the second and third measurements. In cases where either of the measurements was missing, the average was calculated discarding the missing value. |
Harmonized/Clinical Data | |
nsrr_age
Subject age
|
Subject age
Harmonized by the NSRR team to align with TOPMed and BioDataCatalyst standards. Source: age_s1 at Visit 1 and age_s2 at Visit 2 |
Harmonized/Demographics | |
nsrr_age_gt89
Indicates whether the subject's age (in years) used during date obfuscation is greater than 89 years
|
Indicates whether the subject's age (in years) used during date obfuscation is greater than 89 years
Harmonized by the NSRR team to align with TOPMed and BioDataCatalyst standards. Source: age_s1 at Visit 1 and age_s2 at Visit 2 |
Harmonized/Demographics | |
nsrr_ethnicity
Subject ethnicity
|
Subject ethnicity
Original missing value is recoded as "not reported". |
Harmonized/Demographics | |
nsrr_race
Subject race
|
Subject race
Harmonized by the NSRR team to align with TOPMed and BioDataCatalyst standards. Source: race |
Harmonized/Demographics | |
nsrr_sex
Subject sex
|
Subject sex
Harmonized by the NSRR team to align with TOPMed and BioDataCatalyst standards. Source: gender |
Harmonized/Demographics | |
nsrr_current_smoker
Currently smoking cigarettes
|
Currently smoking cigarettes
Indicates whether subject currently smokes cigarettes. |
Harmonized/Lifestyle and Behavioral Health | |
nsrr_ever_smoker
Ever smoked cigarettes
|
Ever smoked cigarettes
Indicates whether subject ever regularly smoked cigarettes. |
Harmonized/Lifestyle and Behavioral Health | |
nsrr_ahi_hp3r_aasm15
Apnea-Hypopnea Index : (All apneas + hypopneas with >=30% nasal cannula [or alternative sensor] reduction and >= 3% oxygen desaturation or with arousal) / hour of sleep
|
Apnea-Hypopnea Index : (All apneas + hypopneas with >=30% nasal cannula [or alternative sensor] reduction and >= 3% oxygen desaturation or with arousal) / hour of sleep
Harmonized by the NSRR team. |
Harmonized/Polysomnography/Apnea-Hypopnea Indices | |
nsrr_ahi_hp3u
Apnea-Hypopnea Index : (All apneas + hypopneas with >= 3% oxygen desaturation) / hour of sleep
|
Apnea-Hypopnea Index : (All apneas + hypopneas with >= 3% oxygen desaturation) / hour of sleep
Harmonized by the NSRR team. Refer to the source for detailed definition for respiratory events: ahi_a0h3 |
Harmonized/Polysomnography/Apnea-Hypopnea Indices | |
nsrr_ahi_hp4r
Apnea-Hypopnea Index : (All apneas + hypopneas with >= 4% oxygen desaturation or with arousal) / hour of sleep
|
Apnea-Hypopnea Index : (All apneas + hypopneas with >= 4% oxygen desaturation or with arousal) / hour of sleep
Harmonized by the NSRR team. Refer to the source for detailed definition for respiratory events: ahi_a0h4a |
Harmonized/Polysomnography/Apnea-Hypopnea Indices | |
nsrr_ahi_hp4u_aasm15
Apnea-Hypopnea Index : (All apneas + hypopneas with >=30% nasal cannula [or alternative sensor] reduction with >= 4% oxygen desaturation) / hour of sleep
|
Apnea-Hypopnea Index : (All apneas + hypopneas with >=30% nasal cannula [or alternative sensor] reduction with >= 4% oxygen desaturation) / hour of sleep
Harmonized by the NSRR team. |
Harmonized/Polysomnography/Apnea-Hypopnea Indices | |
nsrr_phrnumar_f1
Arousal Index: Number of arousals per hour of sleep from polysomnography
|
Arousal Index: Number of arousals per hour of sleep from polysomnography
Harmonized by the NSRR team. Source: ai_all |
Harmonized/Polysomnography/Arousal | |
nsrr_pctdursp_s1
Percentage of total sleep duration (i.e., total sleep time, TST) in stage 1 from polysomnography
|
Percentage of total sleep duration (i.e., total sleep time, TST) in stage 1 from polysomnography
Harmonized by the NSRR team. Source: timest1p |
Harmonized/Polysomnography/Sleep Architecture | |
nsrr_pctdursp_s2
Percentage of total sleep duration (i.e., total sleep time, TST) in stage 2 from polysomnography
|
Percentage of total sleep duration (i.e., total sleep time, TST) in stage 2 from polysomnography
Harmonized by the NSRR team. Source: timest2p |
Harmonized/Polysomnography/Sleep Architecture | |
nsrr_pctdursp_s3
Percentage of total sleep duration (i.e., total sleep time, TST) in stage 3/4 from polysomnography
|
Percentage of total sleep duration (i.e., total sleep time, TST) in stage 3/4 from polysomnography
Harmonized by the NSRR team. Source: times34p |
Harmonized/Polysomnography/Sleep Architecture | |
nsrr_pctdursp_sr
Percentage of total sleep duration (i.e., total sleep time, TST) in REM from polysomnography
|
Percentage of total sleep duration (i.e., total sleep time, TST) in REM from polysomnography
Harmonized by the NSRR team. Source: timeremp |
Harmonized/Polysomnography/Sleep Architecture | |
nsrr_ttldursp_f1
Total Sleep Duration: the interval between sleep onset and sleep offset while the participant is asleep from polysomnography
|
Total Sleep Duration: the interval between sleep onset and sleep offset while the participant is asleep from polysomnography
Conventionally, this would be called total sleep time (TST) (i.e. total time spent in stage 1 or greater). |
Harmonized/Polysomnography/Sleep Architecture | |
nsrr_ttldursp_s1sr
REM Sleep Latency: the interval between the first sleep epoch and REM sleep excluding wake
|
REM Sleep Latency: the interval between the first sleep epoch and REM sleep excluding wake
Harmonized by the NSRR team. Source: remlaiip |
Harmonized/Polysomnography/Sleep Architecture | |
nsrr_ttldurws_f1
Wake After Sleep Onset: the total duration being awake between sleep onset and lights-on/out-bed time from polysomnography
|
Wake After Sleep Onset: the total duration being awake between sleep onset and lights-on/out-bed time from polysomnography
Harmonized by the NSRR team. Source: waso |
Harmonized/Polysomnography/Sleep Architecture | |
nsrr_ttleffsp_f1
Sleep Efficiency: the ratio of total sleep duration (i.e., total sleep time) to in-bed period (i.e., time in bed) from polysomnography
|
Sleep Efficiency: the ratio of total sleep duration (i.e., total sleep time) to in-bed period (i.e., time in bed) from polysomnography
Harmonized by the NSRR team. Source: slpeffp |
Harmonized/Polysomnography/Sleep Architecture | |
nsrr_ttllatsp_f1
Sleep Latency: the interval between lights-out/in-bed time and sleep onset from polysomnography
|
Sleep Latency: the interval between lights-out/in-bed time and sleep onset from polysomnography
Harmonized by the NSRR team. Source: slplatp |
Harmonized/Polysomnography/Sleep Architecture | |
nsrr_ttlprdbd_f1
Total In-bed Period: the interval between lights off/in-bed time and lights on/out-bed time from polysomnography
|
Total In-bed Period: the interval between lights off/in-bed time and lights on/out-bed time from polysomnography
Harmonized by the NSRR team. Conventionally, this would be called time in bed (TIB) |
Harmonized/Polysomnography/Sleep Architecture | |
nsrr_ttlprdsp_s1sr
REM Sleep Latency: the interval between the first sleep epoch and REM sleep including wake
|
REM Sleep Latency: the interval between the first sleep epoch and REM sleep including wake
Harmonized by the NSRR team. Source: remlaip |
Harmonized/Polysomnography/Sleep Architecture | |
smokstat_s1
Smoking Status at Sleep Heart Health Study Visit One (SHHS1)
|
Smoking Status at Sleep Heart Health Study Visit One (SHHS1)
Current Smoking Status at the Sleep Heart Health Study Visit One (SHHS1) visit |
Lifestyle and Behavioral Health/SHHS1 | |
smokstat_s2
Smoking Status at Sleep Heart Health Study Visit Two (SHHS2)
|
Smoking Status at Sleep Heart Health Study Visit Two (SHHS2)
Current Smoking Status at the Sleep Heart Health Study Visit Two (SHHS2) |
Lifestyle and Behavioral Health/SHHS2 | |
ace1
angiotensin-converting-enzyme inhibitor (ACE) inhibitors without diuretics (Sleep Heart Health Study Visit One (SHHS1))
|
angiotensin-converting-enzyme inhibitor (ACE) inhibitors without diuretics (Sleep Heart Health Study Visit One (SHHS1))
Participant taking angiotensin-converting-enzyme inhibitor (ACE) INHIBITORS WITHOUT DIURETICS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS1 | |
aced1
angiotensin-converting-enzyme inhibitor (ACE) inhibitors with diuretics (Sleep Heart Health Study Visit One (SHHS1))
|
angiotensin-converting-enzyme inhibitor (ACE) inhibitors with diuretics (Sleep Heart Health Study Visit One (SHHS1))
Participant taking angiotensin-converting-enzyme inhibitor (ACE) INHIBITORS WITH DIURETICS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS1 | |
anar1a1
Anti-Arrhythmics, Class 1A (Sleep Heart Health Study Visit One (SHHS1))
|
Anti-Arrhythmics, Class 1A (Sleep Heart Health Study Visit One (SHHS1))
Participant taking ANTI-ARRHYTHMICS, CLASS 1A within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS1 | |
anar1b1
Anti-Arrhythmics, Class 1B (Sleep Heart Health Study Visit One (SHHS1))
|
Anti-Arrhythmics, Class 1B (Sleep Heart Health Study Visit One (SHHS1))
Participant taking ANTI-ARRHYTHMICS, CLASS 1B within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS1 | |
anar1c1
Anti-Arrhythmics, Class 1C (Sleep Heart Health Study Visit One (SHHS1))
|
Anti-Arrhythmics, Class 1C (Sleep Heart Health Study Visit One (SHHS1))
Participant taking ANTI-ARRHYTHMICS, CLASS 1C within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS1 | |
anar31
Anti-Arrhythmics, Class 3 (Sleep Heart Health Study Visit One (SHHS1))
|
Anti-Arrhythmics, Class 3 (Sleep Heart Health Study Visit One (SHHS1))
Participant taking ANTI-ARRHYTHMICS, CLASS 3 within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS1 | |
benzod1
Benzodiazepines (Sleep Heart Health Study Visit One (SHHS1))
|
Benzodiazepines (Sleep Heart Health Study Visit One (SHHS1))
Participant taking BENZODIAZEPINES within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS1 | |
beta1
Beta-blockers without diuretics (Sleep Heart Health Study Visit One (SHHS1))
|
Beta-blockers without diuretics (Sleep Heart Health Study Visit One (SHHS1))
Participant taking BETA-BLOCKERS WITHOUT DIURETICS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS1 | |
betad1
Beta-blockers with diuretics (Sleep Heart Health Study Visit One (SHHS1))
|
Beta-blockers with diuretics (Sleep Heart Health Study Visit One (SHHS1))
Participant taking BETA-BLOCKERS WITH DIURETICS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS1 | |
ccb1
Any calcium-channel blocker = CCIR or CCBSR or CCBT (Sleep Heart Health Study Visit One (SHHS1))
|
Any calcium-channel blocker = CCIR or CCBSR or CCBT (Sleep Heart Health Study Visit One (SHHS1))
Participant taking ANY CALCIUM-CHANNEL BLOCKER = CCIR OR CCBSR OR CCBT within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS1 | |
diuret1
Any diuretic (Sleep Heart Health Study Visit One (SHHS1))
|
Any diuretic (Sleep Heart Health Study Visit One (SHHS1))
Participant taking ANY DIURETIC within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS1 | |
htnmed1
Any Anti-Hypertensive Medication (Sleep Heart Health Study Visit One (SHHS1))
|
Any Anti-Hypertensive Medication (Sleep Heart Health Study Visit One (SHHS1))
Participant taking ANY ANTI-HYPERTENSIVE MEDICATION within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS1 | |
insuln1
Insulins (Sleep Heart Health Study Visit One (SHHS1))
|
Insulins (Sleep Heart Health Study Visit One (SHHS1))
Participant taking INSULINS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS1 | |
istrd1
Inhaled steroids for asthma (Sleep Heart Health Study Visit One (SHHS1))
|
Inhaled steroids for asthma (Sleep Heart Health Study Visit One (SHHS1))
Participant taking INHALED STEROIDS FOR ASTHMA within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS1 | |
lipid1
Any Lipid-Lowering Medication (Sleep Heart Health Study Visit One (SHHS1))
|
Any Lipid-Lowering Medication (Sleep Heart Health Study Visit One (SHHS1))
Participant taking ANY LIPID-LOWERING MEDICATION within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS1 | |
nsaid1
Non-Steroidal Anti-Inflammatory Agents, Excluding Aspirin (Sleep Heart Health Study Visit One (SHHS1))
|
Non-Steroidal Anti-Inflammatory Agents, Excluding Aspirin (Sleep Heart Health Study Visit One (SHHS1))
Participant taking NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, EXCLUDING ASPIRIN within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS1 | |
ntca1
Non-Tricyclic Antidepressants Other Than monoamine oxidase inhibitor (MAOI) (Sleep Heart Health Study Visit One (SHHS1))
|
Non-Tricyclic Antidepressants Other Than monoamine oxidase inhibitor (MAOI) (Sleep Heart Health Study Visit One (SHHS1))
Participant taking NON-TRICYCLIC ANTIDEPRESSANTS OTHER THAN monoamine oxidase inhibitor (MAOI) within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS1 | |
ntg1
Nitrates (Sleep Heart Health Study Visit One (SHHS1))
|
Nitrates (Sleep Heart Health Study Visit One (SHHS1))
Participant taking NITRATES within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS1 | |
ohga1
Oral Hypoglycemic Agents (Sleep Heart Health Study Visit One (SHHS1))
|
Oral Hypoglycemic Agents (Sleep Heart Health Study Visit One (SHHS1))
Participant taking ORAL HYPOGLYCEMIC AGENTS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review. |
Medical History/Medications/SHHS1 |